Karnataka Bioeconomy Reaches $39 Billion
Analysis based on 6 articles · First reported Feb 23, 2026 · Last updated Feb 25, 2026
The strong growth of India — Karnataka's bioeconomy, reaching $39.21 billion and contributing significantly to its GSDP and India's national bioeconomy, signals a positive outlook for the biotechnology sector. This development is likely to attract further investment into India — Karnataka, particularly in BioPharma, BioIndustrial, and BioServices segments, benefiting companies operating in these areas.
India — Karnataka's bioeconomy reached a record $39.21 billion in 2025, marking a 26.5% growth over 2023. This sector now contributes over one-fifth to India's national bioeconomy and more than 10% to India — Karnataka's Gross State Domestic Product (GSDP). The BioEconomy Report 2025, released by IT/BT minister Priyank Kharge and jointly prepared by India — Karnataka Innovation and Technology Society (KITS) and Association of Biotechnology Led Enterprises (ABLE), highlights the transition from a science-led sector to a production-oriented bio-based economy. BioPharma remains the largest segment, while BioIndustrial biotechnology emerged as the fastest-growing. The state is home to 1,451 biotechnology and life science startups, with 218 new additions in 2025. India — Karnataka attracted $1.14 billion in investments across 40 deals between January 2024 and October 2025, reflecting rising investor confidence. Regional clusters like India — Bengaluru, India — Mysore, India — Belgaum, and India — Dakshina Kannada are gaining momentum, with the government supporting innovation parks and centers of excellence.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard